Written & medically reviewed by Dr. Sanjay Anbu, MBBS· Last reviewed
Degludec is an ultra-long-acting background insulin. It belongs to the Injectable diabetes medicine (insulin analogue & GLP-1) group. These injectable medicines control blood sugar; GLP-1 types also aid weight loss.
Injectable diabetes medicine (insulin analogue & GLP-1)
Type
Prescription
Dose
Individual — ask your doctor or pharmacist
What it is used for
Type 2 diabetes not controlled on tablets
Type 1 diabetes (insulins)
Weight management (some GLP-1s)
Heart/kidney protection (some GLP-1s)
Common brand names
India: Tresiba
Worldwide: Tresiba
Common side effects
Low blood sugar (insulins)
Nausea, especially early (GLP-1s)
Injection-site reactions
Before taking it — precautions
Rotate injection sites; store as directed
GLP-1s are started low to limit nausea
Match insulin to meals; never skip meals after a dose
When to see a doctor urgently
Severe low sugar: confusion, fainting (emergency)
Severe abdominal pain (rare pancreatitis with GLP-1s)
Very high sugar with vomiting/drowsiness
Not a prescription — no dose shown. The right dose of insulin degludec depends on age, weight, kidney/liver function and the condition, so MedDroid does not show a dose here. Always get your dose from a doctor or pharmacist and the leaflet inside the pack. General educational information only.
Frequently asked questions
Do GLP-1 medicines cause weight loss?
Yes — several (like semaglutide and liraglutide) reduce appetite and support weight loss, alongside lowering blood sugar.
What is the difference between long- and rapid-acting insulin?
Long-acting (like glargine, degludec) gives steady background cover; rapid-acting (like aspart, lispro) covers meals. Many people use both.
Reviewed by Dr. Sanjay Anbu, MBBS. MedDroid is an AI medical assistant and can make mistakes. It provides general health information, not a diagnosis or medical advice — always consult a qualified clinician. In an emergency, contact your local emergency number immediately.